Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic Drug Monitoring of Levofloxacin in MDR-TB Patients

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02379-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Evaluation of Saliva as an Alternative Matrix for Monitoring Plasma Zidovudine, Lamivudine and Nevirapine Concentrations in Rwanda

Current HIV Research
VirologyInfectious Diseases
2011English

Saliva as a Diagnostic Matrix for Drug Abuse

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2005English

Ireland’s Potential MDR-TB and XDR-TB Problem

Irish Journal of Medical Science
Medicine
2010English

Pharmacokinetics of Levofloxacin in Children Treated for Drug-Resistant TB Exposure

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Heightened Vulnerability to MDR-TB Epidemics After Controlling Drug-Susceptible TB

PLoS ONE
Multidisciplinary
2010English

Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-Tb) Among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh

Journal of Tuberculosis Research
2018English

Therapeutic Drug Monitoring of Micophenolate Mofetil in Cardiac Transplant Patients by Limited Sampling Strategy: An Update

2019English

Potential Drug–drug Interactions Between Antiretroviral Therapy and Treatment Regimens for Multi-Drug Resistant Tuberculosis: Implications for HIV Care of MDR-TB Co-Infected Individuals

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy